MDSCs suppress T cell proliferation and cytotoxicity through IL-10 and TGF-β secretion, while TAMs block T cell recognition through tumor antigen phagocytosis, ultimately forming an immune paralysis state of “enhanced antigen presentation but ineffective immune killing,” with ADM serving as the critical regulatory hub of this pathological process. This evidence concerns the gene TGFB1 and neoplasm.